NCT04109599

Brief Summary

This study's specific aims were to: develop a digital intervention as a prevention intervention through focus groups with 40 youth; pilot-test the developed digital intervention with 30 adolescents, using methods from the investigator's prior research; develop implementation strategies and partners through focus groups with 50 School Based Health Alliance affiliates and 30 adolescents from an Advisory Council.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 27, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 30, 2019

Completed
1.4 years until next milestone

Study Start

First participant enrolled

March 1, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2021

Completed
10 months until next milestone

Results Posted

Study results publicly available

July 8, 2022

Completed
Last Updated

July 8, 2022

Status Verified

June 1, 2022

Enrollment Period

6 months

First QC Date

September 27, 2019

Results QC Date

January 26, 2022

Last Update Submit

June 15, 2022

Conditions

Outcome Measures

Primary Outcomes (6)

  • Knowledge Questions

    Participants were asked 5 true/false knowledge questions pre/post gameplay.

    Post Gameplay, up to 1 week

  • Perception of Risk of Harm

    Participants were asked 5 perception of harm questions then asked to rate the questions on a 4-point scale (no risk to great risk). Change in perception of risk of harm pre/post gameplay was measured to assess this outcome.

    Post Gameplay, up to 1 week

  • Gameplay Experience

    Gameplay experience was assessed using 8 statements to be rated on a scale of 1-5 (1= Not at all, 5= A lot) such as "I was absorbed in this experience" and "I understood the stories in PlaySmart." Each item was assessed individually to assess gameplay experience.

    Post Gameplay, up to 1 week

  • Beta Test a Storyline of PlaySmart Game

    Each storyline was randomly tested by 4 users and they provided qualitative feedback during focus groups post gameplay. Presented are counts of participants that successfully completed this task.

    Post Gameplay, up to 1.5 hour

  • Beta Test PlaySmart Risk Sense Mini Game

    Each level of the Risk Sense mini game was randomly tested by 3 users and they provided qualitative feedback during focus groups post gameplay. Presented are counts of participants that successfully completed this task.

    Post Gameplay, up to 1.5 hour

  • Beta Test PlaySmart Full Game: Character Development Focus

    The PlaySmart Full Game was randomly tested by 3 users and they provided qualitative feedback during focus groups post gameplay focused on character development. Presented are counts of participants that successfully completed the task.

    Post Gameplay, up to 1 week

Study Arms (9)

PlaySmart Full Game

EXPERIMENTAL

Adolescents, boys and girls, aged 16-19 participated in the pilot testing of the adapted game. PlaySmart is a digital intervention targeted towards preventing opioid misuse in older adolescents.

Behavioral: PlaySmart

Trading Wisdom Storyline

EXPERIMENTAL

Adolescents, boys and girls, aged 16-19 participated in beta testing this PlaySmart storyline where the player receives an opioid prescription from their dentist. This storyline includes information about safe use of opioids and the difference between use and misuse.

Behavioral: PlaySmart Storyline

Lean on Me Storyline

EXPERIMENTAL

Adolescents, boys and girls, aged 16-19 participated in beta testing this PlaySmart storyline where the player is offered opioids at a party. This storyline includes information about different forms of opioids and their effects.

Behavioral: PlaySmart Storyline

Tough Love Storyline

EXPERIMENTAL

Adolescents, boys and girls, aged 16-19 participated in beta testing this PlaySmart storyline where the player navigates supporting their partner struggling with opioid misuse. This storyline includes information about treatment and recovery resources for opioid misuse \& Opioid Use Disorder.

Behavioral: PlaySmart Storyline

Grandma's Pills Storyline

EXPERIMENTAL

Adolescents, boys and girls, aged 16-19 participated in beta testing this PlaySmart storyline where the player witnesses the sharing of an opioid prescription within their family. This storyline includes information about medication safety and opioid overdose identification and response.

Behavioral: PlaySmart Storyline

A Friend in Need Storyline

EXPERIMENTAL

Adolescents, boys and girls, aged 16-19 participated in beta testing this PlaySmart storyline where the player interacts with a friend that is in distress. This storyline includes information about how to navigate peer-to-peer support.

Behavioral: PlaySmart Storyline

A New Direction Storyline

EXPERIMENTAL

Adolescents, boys and girls, aged 16-19 participated in beta testing this PlaySmart storyline where the player seeks out therapy as an option to manage stress. This storyline includes information about how to seek professional help for mental health.

Behavioral: PlaySmart Storyline

Risk Sense All Levels

EXPERIMENTAL

Adolescents, boys and girls, aged 16-19 participated in beta testing all levels of this PlaySmart mini game intended to increase perceived risk of harm of opioid misuse.

Behavioral: Play Smart Mini-Game

PlaySmart Full Game: Focus on Character Development

EXPERIMENTAL

Adolescents, boys and girls, aged 16-19 participated in the pilot testing of the adapted game. PlaySmart is a digital intervention targeted towards preventing opioid misuse in older adolescents. Participants in this arm focused on beta testing character development aspects throughout the game.

Behavioral: PlaySmart

Interventions

PlaySmartBEHAVIORAL

Participants played the developed PlaySmart game over the course of a week.

PlaySmart Full GamePlaySmart Full Game: Focus on Character Development

Participants played through one PlaySmart Storyline during one 1-1.5 hour session.

A Friend in Need StorylineA New Direction StorylineGrandma's Pills StorylineLean on Me StorylineTough Love StorylineTrading Wisdom Storyline

Participants played through all levels of the PlaySmart Risk Sense mini-game during one 1-1.5 hour session.

Risk Sense All Levels

Eligibility Criteria

Age16 Years - 19 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Adolescent participants must attend high school that has a school-based health center, to participate in pilot testing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yale School of Medicine

New Haven, Connecticut, 06519, United States

Location

MeSH Terms

Conditions

Opioid-Related Disorders

Condition Hierarchy (Ancestors)

Narcotic-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Results Point of Contact

Title
Tyra Pendergrass Boomer, Deputy Director of Programs and Partnerships
Organization
play2PREVENT Lab, Yale Center for Health and Learning Games, Department of Internal Medicine

Study Officials

  • Lynn E Fiellin, MD

    Director, play2PREVENT Lab at Yale, Internal Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 27, 2019

First Posted

September 30, 2019

Study Start

March 1, 2021

Primary Completion

August 31, 2021

Study Completion

August 31, 2021

Last Updated

July 8, 2022

Results First Posted

July 8, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

Locations